Cholest-5-ene

Cholest-5-ene is a lipid of Sterol Lipids (ST) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1327 references associated with Cholest-5-ene in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Cholest-5-ene

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cholest-5-ene

MeSH term MeSH ID Detail
Arteriosclerosis D001161 86 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Insulin Resistance D007333 99 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Total 5

NCBI Entrez Crosslinks

All references with Cholest-5-ene

Download all related citations
Per page 10 20 50 100 | Total 341
Authors Title Published Journal PubMed Link
Fujioka-Kobayashi M et al. Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. 2012 Biomaterials pmid:22800537
Van Laar TA et al. Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi. 2012 PLoS ONE pmid:22675445
Shimamura M and Hidaka H Therapeutic potential of cholesteryl O-acyl α-glucoside found in Helicobacter pylori. 2012 Curr. Med. Chem. pmid:22934809
Son SH et al. Perilipin 2 (PLIN2)-deficiency does not increase cholesterol-induced toxicity in macrophages. 2012 PLoS ONE pmid:22427949
Estronca LM et al. Molecular etiology of atherogenesis--in vitro induction of lipidosis in macrophages with a new LDL model. 2012 PLoS ONE pmid:22514671
Mulvihill EE and Huff MW Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation. 2012 PPAR Res pmid:22701469
Parisio G et al. Flip-flop of steroids in phospholipid bilayers: effects of the chemical structure on transbilayer diffusion. 2012 J. Am. Chem. Soc. pmid:22738146
Schreiber R et al. Retinyl ester hydrolases and their roles in vitamin A homeostasis. 2012 Biochim. Biophys. Acta pmid:21586336
Ishikawa K et al. Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice. 2012 Int J Hypertens pmid:22518297
Schroeder ME et al. Elucidation of the Rotavirus NSP4-Caveolin-1 and -Cholesterol Interactions Using Synthetic Peptides. 2012 J Amino Acids pmid:22500212
Ancelin ML et al. Lipid lowering agents, cognitive decline, and dementia: the three-city study. 2012 J. Alzheimers Dis. pmid:22451317
Yi DW et al. The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein B. 2012 Diabetes Metab J pmid:22363922
Yu SS et al. Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. 2012 Int J Nanomedicine pmid:22359457
Shi F et al. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil. 2012 Int J Nanomedicine pmid:22619540
Mével M et al. Paromomycin and neomycin B derived cationic lipids: synthesis and transfection studies. 2012 J Control Release pmid:22226775
Brunzell JD et al. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. 2012 Biochim. Biophys. Acta pmid:21986251
Bei WJ et al. Lipid-regulating effect of traditional chinese medicine: mechanisms of actions. 2012 Evid Based Complement Alternat Med pmid:22611438
Go GW and Mani A Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. 2012 Yale J Biol Med pmid:22461740
Schneider AC et al. Conversion of t11t13 CLA into c9t11 CLA in Caco-2 cells and inhibition by sterculic oil. 2012 PLoS ONE pmid:22427892
Wang HJ et al. Helicobacter pylori cholesteryl glucosides interfere with host membrane phase and affect type IV secretion system function during infection in AGS cells. 2012 Mol. Microbiol. pmid:22053852